How to Reconstitute Peptides (UK Guide)

A practical guide to reconstituting lyophilised research peptides with bacteriostatic water — volumes, the maths, storage and cold-chain handling.

Reconstitution is the step where most research-peptide work goes wrong — not because it is difficult, but because it is treated casually. This guide covers the two physical states of a peptide, the arithmetic that converts a vial label into a concentration, diluent choice, handling and hygiene, storage and stability, and the UK legal position. It is a laboratory procedure guide, not a dosing guide: nothing here constitutes medical advice, and all products are supplied for research purposes only, not for human or veterinary use.

Why reconstitution is a laboratory procedure, not a protocol

A lyophilised peptide is a dry powder in a sealed vial. To use it in laboratory work you must dissolve it in a measured volume of diluent. The two variables that matter are the mass of peptide in the vial and the volume of diluent added. Everything else — how the resulting solution is handled, stored and applied — is downstream of those two numbers being recorded accurately.

That is why the discipline is documentation first. Record the vial's batch number, the diluent used, the volume added, the date, and the resulting concentration before anything else happens.

Lyophilised versus reconstituted: the two states

Lyophilised (freeze-dried) peptide is the shipped form. It is stable for typically 12–24 months when stored at 2–8 °C, and it is the state in which identity, purity and mass-spectrometry data on the certificate of analysis apply.

Reconstituted peptide is the working form. Once in solution it is far less stable, is vulnerable to freeze–thaw cycling, and is commonly handled within 28 days at 2–8 °C. The practical rule is that lyophilised material is inventory and reconstituted material is a working stock — reconstitute only what the current piece of work needs.

The arithmetic: what the label actually tells you

The label gives the mass of peptide per vial. The diluent volume is your choice, and it sets the concentration. The conversion is straightforward:

• Example: a 5mg vial reconstituted with 1mL of diluent gives 5mg per mL, which is 5,000µg per mL.
• Per 0.1mL of that solution: 500µg.

Change the diluent volume and every downstream figure changes proportionally — 5mg in 2mL gives 2,500µg per mL, and 250µg per 0.1mL. This is arithmetic for calculating concentration in a laboratory setting. It is deliberately not a dose recommendation, and no guidance on administration is provided.

Practical consequence: larger vials are not "stronger". A 60mg vial and a 5mg vial contain the same compound; they simply require different diluent volumes to reach a target concentration.

Bacteriostatic water, sterile water and diluent choice

The two common diluents differ in one important way. Bacteriostatic water contains a preservative that suppresses microbial growth, which is why it suits multi-draw vials used across several sessions. Sterile water contains no preservative, so it is generally reserved for single-use preparation.

Bacteriostatic water is the standard choice for multi-draw laboratory vials. Whichever diluent is used, add it slowly down the vial wall rather than directing a stream at the powder, swirl rather than shake to avoid foaming and shear, and allow the pellet to dissolve fully before drawing. Do not mix different peptides in one syringe unless the supplier has confirmed compatibility — pH and osmolarity shifts can denature a peptide.

Handling, hygiene and common mistakes

The recurring errors in reconstitution work are procedural, and all are avoidable:

• Shaking the vial to speed dissolution, which foams the solution and can shear the peptide
• Reconstituting an entire inventory rather than a working stock, then freeze–thawing it repeatedly
• Using unmeasured diluent volumes, which makes the resulting concentration unverifiable
• Re-using a needle across vials, which risks cross-contamination and introduces particulates
• Skipping cleanup of the vial septum before piercing
• Failing to record the batch number alongside the preparation date

Work cleanly, keep a written preparation log, and treat every figure as unverified until it is written down.

Storage and stability

Lyophilised vials belong at 2–8 °C, shielded from light, and are typically stable for 12–24 months. Reconstituted material belongs at 2–8 °C and is commonly used within 28 days. Freeze–thaw cycling of reconstituted peptide degrades it — if aliquoting is necessary, split into single-use portions once, then keep them cold.

Cold chain matters from the moment of dispatch. A peptide that has spent a week in a hot delivery van is a different product from one that has been held at temperature throughout, which is why UK-based dispatch with cool packs is a material quality variable rather than a marketing claim.

Is it legal in the UK?

Reconstitution is not itself regulated, but the products you reconstitute are. No research peptide sold in the UK is a controlled substance under the Misuse of Drugs Act 1971. The MHRA treats peptides sold for human use as unlicensed medicines, and enforcement is aimed at sellers, suppliers and clinics rather than individual importers. Personal importation of small quantities is a grey zone — tolerated in practice, not explicitly legal — and seizure typically results in confiscation rather than prosecution. UK customs enforcement on peptides has been assessed as the least aggressive of the five major markets.

The "for research purposes only" label is a real but soft shield: the MHRA has indicated it may disregard it where the label is used to evade medicines regulation, and it treats GLP-1-class compounds as the highest-risk "research" category. Enforcement is active — a February 2026 Lincolnshire raid seized around 2,000 doses of unlicensed weight-loss drugs, an October 2025 Northampton seizure took 2,000-plus pens, and in April 2026 the MHRA opened an investigation into UK peptide clinics over health claims. Sourcing from UK stock removes border exposure, including the 20% import VAT and potential seizure that international orders can attract.

Where this fits at Peptide Supply Guy

Everything needed to prepare laboratory vials is stocked in the UK:

• Bacteriostatic water, 3mL × 10 vials — £2.55 per vial (card price)
• Bacteriostatic water, 10mL × 10 vials — £3.40 per vial (card price)
• BPC-157 5mg — £9.35 per vial (card price), a common starting point for reconstitution practice

Every batch ships from UK stock with a certificate of analysis, and every compound is supplied strictly for research purposes only. If you are new to laboratory preparation, start with recorded volume and a written log rather than speed.